Noronex Limited has completed the sale of its non-core Dordabis Copper Project in Namibia, receiving the final payment and strengthening its cash position to advance exploration in higher-priority uranium and copper assets.
- Sale of Dordabis Project completed with total consideration of N$11.5 million
- Final payment of N$5 million received, satisfying transaction conditions
- JV partner Larchmont Holdings opts for 50% cash and 50% Noronex shares
- Noronex retains 11.2% equity in Dordabis post-sale; Umino assumes majority ownership
- Funds to support exploration at Namibian uranium and copper projects
Strategic Divestment Completed
Noronex Limited (ASX:NRX) has officially closed the chapter on its non-core Dordabis Copper Project in Namibia, marking a significant step in its strategic realignment. The company received the final payment of N$5 million (approximately A$440,000), completing the total sale consideration of N$11.5 million to Umino (Pty) Ltd. This transaction effectively transfers majority ownership of the Dordabis licence, which accounts for about 2% of Noronex’s Namibian tenure, to Umino.
Joint Venture Partner’s Share Allocation
Noronex’s joint venture partner, Larchmont Holdings, which holds a 20% stake in the Dordabis asset, has elected to receive half of its final payment in cash and the other half in Noronex shares. This decision not only reflects Larchmont’s confidence in Noronex’s broader portfolio but also injects additional liquidity into the company. The shares will be issued at $0.014 each, resulting in over seven million new shares allocated to Larchmont.
Implications for Noronex’s Portfolio
With the Dordabis divestment behind it, Noronex is poised to sharpen its focus on its core assets, particularly its uranium and copper projects within Namibia’s prolific Kalahari Copper Belt. The company’s Managing Director and CEO, Victor Rajasooriar, highlighted that the proceeds will be channelled into advancing exploration efforts at high-potential sites such as the Humpback, Damara, and Powerline projects. These areas are currently under active drilling programs, supported by earn-in agreements with South32, which further underscores Noronex’s commitment to unlocking value in its primary holdings.
Financial and Operational Impact
The transaction not only streamlines Noronex’s asset base but also strengthens its balance sheet, providing a more robust financial footing for upcoming exploration phases. Umino now holds 86% of the entity owning the Dordabis licence and assumes all future costs related to exploration and licence maintenance. Additionally, Umino retains an option to acquire the remaining 14% equity within three months, which could further reduce Noronex’s exposure to this non-core asset.
Looking Ahead
This divestment aligns with Noronex’s broader strategy to prioritise projects with the greatest potential for value creation. By reallocating resources and capital, the company aims to accelerate exploration activities in uranium and copper, sectors that remain critical to global energy and industrial demand. The completion of the Dordabis sale thus represents both a tactical retreat from less strategic holdings and a forward-looking investment in growth opportunities.
Bottom Line?
Noronex’s completed sale of Dordabis clears the way for intensified exploration in uranium and copper, setting the stage for its next growth phase.
Questions in the middle?
- How will the issuance of shares to Larchmont Holdings affect Noronex’s share structure and investor sentiment?
- What are the near-term exploration milestones for Noronex’s uranium and copper projects post-divestment?
- Could Umino’s option to acquire the remaining Dordabis equity impact Noronex’s future strategic options?